Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
PHASE3
Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone...
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
PHASE1
This is a multicenter, open-label study conducted in two phases: Phase 1 co...
A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation
PHASE3
The purpose of this study is to evaluate the safety of repeat injections an...
Status
Terminated
Location
California Dermatology & Clinical Research Institute